Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04111939 · ClinicalTrials.gov registry record · NA
HEALing Communities Study
A NA study of Opioid Use Disorder (OUD), sponsored by RTI International.
- Active
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 4
- Study locations
NCT04111939: Active NA study of Opioid Use Disorder (OUD), sponsored by RTI International.
NCT04111939 is a NA study of Opioid Use Disorder (OUD) that is active but no longer recruiting, run by RTI International. The registered enrollment target is 67 participants, below the 308-participant average among 7 other Opioid Use Disorder (OUD) trials with a reported enrollment target (78% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04111939, a NA study of Opioid Use Disorder (OUD), is active but no longer recruiting, sponsored by RTI International.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study will test the impact of implementing the Communities That Helping to End Addiction Long-term (HEAL) intervention on opioid overdose deaths within 67 highly affected communities with the goal of reducing opioid overdose deaths by 40%.
Primary Outcome
Count of HCS community resident overdose deaths (i.e. deaths with an underlying cause of drug poisoning) where opioids were determined to be contributing (alone or in combination with other drugs) to the drug poisoning.
Conditions Studied
Interventions
- OTHER Communities That HEAL
- OTHER Wait-list control
Study Locations (4)
Kentucky
- University of Kentucky - Lexington
Massachusetts
- Boston Medical Center - Boston
New York
- Columbia University - New York
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2019-10-23 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
What the registry record for NCT04111939 still lists
NCT04111939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 308-participant average among 7 other Opioid Use Disorder (OUD) trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Opioid Use Disorder (OUD) appearing as the primary indexed condition, and to 2 interventions - of which Communities That HEAL is the first listed.
NCT04111939 reports a single indexed study location in Kentucky, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT04111939 about?
NCT04111939 is a clinical study titled "HEALing Communities Study". This study will test the impact of implementing the Communities That Helping to End Addiction Long-term (HEAL) intervention on opioid overdose deaths within 67 highly affected communities with the goal of reducing opioid overdose deaths by 40%.
What is the current status of trial NCT04111939?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2019-10-23. Estimated completion is 2025-09-30.
What conditions does trial NCT04111939 study?
This clinical trial studies the following conditions: Opioid Use Disorder (OUD).
What interventions are being tested in trial NCT04111939?
The interventions under investigation include: Communities That HEAL (OTHER), Wait-list control (OTHER).
Who is sponsoring clinical trial NCT04111939?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04111939 being conducted?
This trial has 4 study locations across Kentucky, Massachusetts, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder (OUD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Opioid Adherence and Support Through Innovative Texting Strategies
RECRUITING · NA
-
Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder
RECRUITING · NA
-
SafetyNet Program for Opioid Use Disorder (OUD)
COMPLETED · NA
-
Adjunctive Cannabidiol for Recovery From Opioid Study
RECRUITING · Phase 3
-
Mapping Ibogaine Neural Dynamics in Opioid Use Disorder
RECRUITING
-
MethaLoad Dose-Finding Study
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI